PubMed,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Aug. 19, 2023
Periodontitis
and
Inflammatory
Bowel
Disease
(IBD)
are
chronic
inflammatory
conditions,
characterized
by
microbial
dysbiosis
hyper-immunoinflammatory
responses.
Growing
evidence
suggest
an
interconnection
between
periodontitis
IBD,
implying
a
shift
from
the
traditional
concept
of
independent
diseases
to
complex,
reciprocal
cycle.
This
review
outlines
supporting
"Oral-Gut"
axis,
marked
higher
prevalence
in
IBD
patients
vice
versa.
The
specific
mechanisms
linking
remain
be
fully
elucidated,
but
emerging
points
ectopic
colonization
gut
oral
bacteria,
which
promote
intestinal
inflammation
activating
host
immune
presents
in-depth
examination
highlighting
shared
microbiological
immunological
pathways,
proposing
"multi-hit"
hypothesis
pathogenesis
periodontitis-mediated
inflammation.
Furthermore,
underscores
critical
need
for
collaborative
approach
dentists
gastroenterologists
provide
holistic
oral-systemic
healthcare.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Feb. 22, 2024
Abstract
Periodontitis
is
closely
related
to
inflammatory
bowel
disease
(IBD).
An
excessive
and
non-self-limiting
immune
response
the
dysbiotic
microbiome
characterizes
two.
However,
underlying
mechanisms
that
overlap
still
need
be
clarified.
We
demonstrate
critical
periodontal
pathogen
Porphyromonas
gingivalis
(Pg)
aggravates
intestinal
inflammation
Th17/Treg
cell
imbalance
in
a
gut
microbiota-dependent
manner.
Specifically,
metagenomic
metabolomic
analyses
shows
oral
administration
of
Pg
increases
levels
Bacteroides
phylum
but
decreases
Firmicutes
,
Verrucomicrobia
Actinobacteria
phyla.
Nevertheless,
it
suppresses
linoleic
acid
(LA)
pathway
microbiota,
which
was
target
metabolite
determines
degree
functions
as
an
aryl
hydrocarbon
receptor
(AHR)
ligand
suppress
Th17
differentiation
while
promoting
Treg
via
phosphorylation
Stat1
at
Ser727.
Therapeutically
restoring
LA
colitis
mice
challenged
with
exerts
anti-colitis
effects
by
decreasing
ratio
AHR-dependent
Our
study
suggests
microbiota-LA
metabolism-Th17/Treg
balance
axis,
providing
potential
therapeutically
modifiable
for
IBD
patients
periodontitis.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: Sept. 28, 2023
Ulcerative
colitis
(UC)
is
a
chronic
relapsing
inflammatory
disease
of
the
colorectal
area
that
demonstrates
dramatically
increasing
incidence
worldwide.
This
study
provides
novel
insights
into
capacity
exogenous
β-hydroxybutyrate
and
ketogenic
diet
(KD)
consumption
to
alleviate
dextran
sodium
sulfate
(DSS)-induced
UC
in
rats.
Remarkably,
both
interventions
attenuated
activity
colon
weight-to-length
ratio,
improved
macro
microstructures
damaged
colon.
Importantly,
KD
curbed
DSS-induced
aberrant
NLRP3
inflammasome
activation
as
observed
mRNA
protein
expression
analysis.
Additionally,
inhibition
NLRP3/NGSDMD-mediated
pyroptosis
was
detected
response
regimens.
In
parallel,
these
modalities
caspase-1
its
associated
consequences
IL-1β
IL-18
overproduction.
They
also
mitigated
apoptosis
indicated
by
inactivation
caspase-3.
The
anti-inflammatory
effects
BHB
were
confirmed
reported
decline
levels
markers
including
MPO,
NFκB,
IL-6,
TNF-α.
Moreover,
exhibited
antioxidative
properties
reducing
ROS
production
improving
enzymes.
Their
effectiveness
mitigating
evident
renovation
normal
intestinal
epithelial
barrier
function,
shown
correcting
discrepancies
tight
junction
proteins
ZO-1,
OCLN,
CLDN5.
Furthermore,
their
on
microbiota
homeostasis
investigated.
terms
autophagy,
upregulated
BECN-1
downregulated
p62,
which
may
account
for
superiority
over
attenuating
colonic
damage.
conclusion,
this
experimental
evidence
supporting
potential
therapeutic
use
or
β-hydroxybutyrate-boosting
regimens
UC.
Journal of Crohn s and Colitis,
Journal Year:
2024,
Volume and Issue:
18(8), P. 1319 - 1341
Published: Feb. 28, 2024
As
the
opposite
ends
of
orodigestive
tract,
oral
cavity
and
intestine
share
anatomical,
microbial,
immunological
ties
that
have
bidirectional
health
implications.
A
growing
body
evidence
suggests
an
interconnection
between
pathologies
inflammatory
bowel
disease
[IBD],
implying
a
shift
from
traditional
concept
independent
diseases
to
complex,
reciprocal
cycle.
This
review
outlines
supporting
'oral-gut'
axis,
marked
by
higher
prevalence
periodontitis
other
conditions
in
IBD
patients
vice
versa.
We
present
in-depth
examination
IBD,
highlighting
shared
microbiological
pathways,
proposing
'multi-hit'
hypothesis
pathogenesis
periodontitis-mediated
intestinal
inflammation.
Furthermore,
underscores
critical
need
for
collaborative
approach
dentists
gastroenterologists
provide
holistic
oral-systemic
healthcare.
Journal of Periodontal Research,
Journal Year:
2024,
Volume and Issue:
59(6), P. 1083 - 1094
Published: June 4, 2024
Abstract
The
bidirectional
associations
between
periodontitis
and
inflammatory
bowel
disease
(IBD)
with
temporal
directionality
remain
inconclusive.
This
study
aims
to
evaluate
the
IBD
through
a
systematic
review
meta‐analysis.
Five
databases
(PubMed,
Embase,
Web
of
Science,
Scopus
Cochrane
Library)
were
systematically
searched
from
inception
27
February
2024.
Two
independent
reviewers
performed
retrieved
studies.
Longitudinal
studies,
including
cohort
nested
case–control
considered
eligible
for
design.
pooled
risk
ratio
(RR)
hazard
(HR)
derived
meta‐analysis
used
assess
whether
(or
IBD)
was
factor
periodontitis).
Trial
sequential
analysis
(TSA)
reliability
results.
Four
studies
(
n
=
10
270
912)
on
in
patients
two
33
420)
included.
result
suggested
that
did
not
increase
(pooled
RR
1.04,
95%
confidence
interval
[CI]:
0.99–1.09;
p
.164;
I‐squared
statistic
[
I
2
]
27%).
For
subtypes
IBD,
associated
occurrence
ulcerative
colitis
(UC)
1.12,
CI:
1.04–1.21;
.003;
38%),
but
Crohn's
(CD)
0.98,
0.92–1.04;
.475;
0%).
Specifically,
UC
higher
among
men
HR
1.11,
1.01–1.22;
.025;
0%)
smokers
1.23,
1.07–1.42;
.004;
than
their
counterparts
without
periodontitis.
Patients
may
have
developing
1.37,
1.26–1.49;
<
.001;
18%);
however,
increased
remained
uncertain.
TSA
results
confirmed
primary
findings.
Based
limited
longitudinal
evidence,
do
exhibit
an
overall,
they
are
at
(not
CD).
On
contrary,
over
time.
More
high‐quality
needed
determine
effect
specific
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(5), P. 4626 - 4626
Published: Feb. 27, 2023
Periodontal
diseases
are
oral
inflammatory
affecting
the
tissues
supporting
and
surrounding
teeth
include
gingivitis
periodontitis.
Oral
pathogens
may
lead
to
microbial
products
spreading
into
systemic
circulation
reaching
distant
organs,
while
periodontal
have
been
related
low-grade
inflammation.
Gut
microbiota
alterations
might
play
a
role
in
pathogenesis
of
several
autoimmune
including
arthritis,
considering
gut–joint
axis
regulation
molecular
pathways
involved
these
conditions.
In
this
scenario,
it
is
hypothesized
that
probiotics
contribute
intestinal
micro-ecological
balance
could
reduce
inflammation
typical
arthritis.
This
literature
overview
aims
summarize
state-of-the-art
ideas
about
linkages
among
oral–gut
microbiota,
diseases,
investigating
as
potential
therapeutic
intervention
for
management
both
musculoskeletal
disorders.
Frontiers in Microbiology,
Journal Year:
2023,
Volume and Issue:
14
Published: June 6, 2023
Objectives
Inflammatory
bowel
disease
(IBD)
is
a
chronic
lifelong
inflammatory
disease.
Probiotics
such
as
Bifidobacterium
longum
are
considered
to
be
beneficial
the
recovery
of
intestinal
inflammation
by
interaction
with
gut
microbiota.
Our
goals
were
define
effect
exclusive
use
BAA2573
on
dextran
sulfate
sodium
(DSS)-induced
colitis,
including
improvement
symptoms,
alleviation
histopathological
damage,
and
modulation
Methods
In
present
study,
we
pretreated
C57BL/6J
mice
BAA2573,
one
main
components
in
an
over-the-counter
(OTC)
probiotic
mixture
BIFOTO
capsule,
before
modeling
DSS.
16S
rDNA
sequencing
liquid
chromatography–tandem
mass
spectrometry
(LC-MS/MS)-based
non-targeted
metabolomic
profiling
performed
collected
feces.
Results
We
found
that
pretreatment
given
gavage
significantly
improved
symptoms
damage
DSS-induced
colitis
mice.
After
intervention,
57
genera
39
metabolites
altered.
Pathway
enrichment
analysis
demonstrated
starch
sucrose
metabolism,
vitamin
B6
sphingolipid
metabolism
may
contribute
ameliorating
colitis.
Moreover,
revealed
microbiome
interrelated
intervention
group,
while
Alistipes
was
core
genus.
Conclusion
study
demonstrates
impact
microbiota
reveals
possible
novel
adjuvant
therapy
for
IBD
patients.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 5, 2025
Ulcerative
colitis
is
a
chronic
disease
that
has
not
well-established
etiology.
The
role
of
microbial
dysregulation
in
its
pathogenesis
been
recently
highlighted.
Overall,
microbiome
alterations
concern
the
reduction
bacterial
abundance
and
diversity,
resulting
gut
imbalance
negatively
affecting
immunological
aspects.
There
link
between
ulcerative
oral
microbiome.
changes
are
found
at
many
levels,
from
gently
dysbiotic
composition
to
presence
main
periodontal
microbes.
analysis
can
be
part
personalized
medicine
due
fact
it
potential
biomarker.
Patients
with
may
manifest
dental
symptoms/problems,
such
as
periodontitis
(strongly
related
red-complex
pathogens—
Porphyromonas
gingivalis
,
Tannerella
forsythia
Treponema
denticola
bacteria
belonging
other
complexes,
Fusobacterium
nucleatum
Aggregatibacter
actinomycetecomitans
),
caries,
ulcerations,
leukoplakia,
halitosis,
others.
Notably,
DMFT
(Decayed,
Missing,
Filled
Teeth)
index
higher
these
patients
compared
healthy
subjects.
According
some
data,
lichen
planus
(which
an
background)
also
observed
patients.
It
seems
deep
understanding
association
microbiome,
immunology,
manifestations
crucial
provide
complex
treatment
point
view.
Scientific Data,
Journal Year:
2025,
Volume and Issue:
12(1)
Published: Feb. 19, 2025
The
oral
microbiome
plays
a
crucial
role
in
maintaining
health,
with
Streptococcus
salivarius
recognized
for
its
beneficial
probiotic
functions,
including
inhibiting
pathogenic
bacteria
and
supporting
immune
regulation,
particularly
healthy
individuals.
While
research
on
S.
has
primarily
focused
strains
originating
from
non-Asian
populations,
New
Zealand,
some
studies
also
reporting
European
strains,
Korea
been
notably
lacking.
This
dataset
provides
the
complete
genome
sequences
transcriptomic
profiles
of
12
isolated
Korean
PacBio
SMRTbell
technology
was
employed
sequencing.
Our
includes
data
that
reveal
functional
gene
expression
patterns
under
standard
growth
conditions.
analyzed
here
are
valuable
as
each
exhibits
unique
interaction
Fusobacterium
nucleatum,
pathogen
associated
periodontal
disease
colorectal
cancer,
collectively
demonstrating
diverse
interaction.
By
offering
comprehensive
strain
variation,
this
resource
can
serve
tool
aimed
at
understanding
utilizing
bacteria.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2025,
Volume and Issue:
15
Published: April 7, 2025
Fusobacterium
nucleatum
(F.
nucleatum)
is
an
anaerobic
bacterium
known
for
its
association
with
periodontal
disease
and
oral
infections.
It
has
been
implicated
in
the
development
of
gastrointestinal
diseases
such
as
inflammatory
bowel
colorectal
cancer.
Ulcerative
colitis
(UC),
which
characterized
by
chronic
inflammation
colon,
a
condition
unknown
etiology
rising
incidence
rate,
significantly
affecting
quality
life
patients.
The
increased
intestinal
permeability
during
UC
may
facilitate
adherence
or
invasion
F.
into
damaged
barrier,
leading
to
exacerbated
inflammation.
This
article
introduces
concept
oral-gut
axis,
reviewing
existing
literature
analyze
role
pathogenesis
exploring
potential
pathogenic
mechanisms.
also
summarizes
latest
advances
treating
patients
who
have
looks
forward
prospective
therapeutic
strategies
translational
prospects
within
axis.
be
key
player
UC,
likely
due
invasiveness
periods
permeability.
paper
discusses
innovative
approaches
prevention
management
nucleatum,
paving
way
more
effective
treatment
UC.
review
offers
new
insights
complex
relationship
between
microbiome
diseases,
enhancing
our
understanding
their
dynamic
interactions.
There
paucity
on
approaches,
indicating
need
further
clinical
research.